Protocol Details

Magnetic Resonance Imaging at 1.5 and 3.0 Tesla

This study is currently recruiting participants.

Summary | Eligibility | Citations | Contacts

Summary

Number	87-CC-0091
Sponsoring Institute	National Institutes of Health Clinical Center (CC)
Recruitment Detail	Type: Participants currently recruited/enrolled Gender: Male & Female Min Age: N/A Max Age: N/A
Referral Letter Required	No
Population Exclusion(s)	None
Special Instructions	Currently Not Provided
Keywords	Surface Coils; T1-Weighted Images; T2-Weighted Images; Pulse Sequences; Spin Echo; Inversion Recovery; Partial Saturation; GRASS
Recruitment Keyword(s)	None
Condition(s)	Healthy
Investigational Drug(s)	None
Investigational Device(s)	None
Intervention(s)	None
Supporting Site	NIH Clinical Center

Magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) are diagnostic tests that allow researchers to look at different chemical properties of tissue. Magnetic resonance imaging and spectroscopy studies can be used to gather or evaluate information about various aspects of patient's bodies or to monitor changes in the biochemistry and physiology of patient's bodies.

Unlike other diagnostic techniques (CT scan and PET scan) MRI and MRS do not use ionizing radiation. Some studies have shown that MRI is more effective at distinguishing normal parts of the anatomy from abnormal anatomy, especially in the brain. MRI has become the diagnostic test of choice for evaluating patient with multiple sclerosis.

The purpose of this study is to evaluate normal volunteers and patients with a variety of diseases with magnetic resonance imaging. Researchers will attempt different magnetic resonance imaging methods and techniques as well as different levels of magnetic strength.

--Back to Top--

Eligibility

INCLUSION CRITERIA:

All patients undergoing MRI in the Clinical Center.

Patients must be able to provide informed consents.

EXCLUSION CRITERIA:

No contraindications to MRI.

Inability to understand consent form or consent process and the absence of a suitable guardian.

Refusal to Participate.

--Back to Top--

Citations:

Nuclear magnetic resonance imaging in oncology

Surface coil proton MR imaging at 2 TE

Cyclosporin-Anephroxity and acute cellular rejection in renal transplant recipients: correlation between radionuclide and histologic findings

--Back to Top--

Contacts:

Principal Investigator	Referral Contact	For more information:
John A. Butman, M.D. National Institutes of Health Clinical Center (CC) National Institutes of Health Building 10 Room 1C360 10 Center Drive Bethesda, Maryland 20892 (301) 402-5827 JButmanA@cc.nih.gov	John A. Butman, M.D. National Institutes of Health Clinical Center (CC) National Institutes of Health Building 10 Room 1C360 10 Center Drive Bethesda, Maryland 20892 (301) 402-5827 JButmanA@cc.nih.gov	Patient Recruitment and Public Liaison Office Building 61 10 Cloister Court Bethesda, Maryland 20892-4754 Toll Free: 1-800-411-1222 TTY: 301-594-9774 (local),1-866-411-1010 (toll free) Fax: 301-480-9793 prpl@mail.cc.nih.gov

Clinical Trials Number:

NCT00001219

--Back to Top--

QUESTIONS?

Contact the Patient Recruitment and Public Liaison Office for:

• Details on how to participate in a study
• Details on how to refer a patient to a study

NIH Clinical Studies Information Request

---

Contact the Office of Communications for:

• General information about the NIH Clinical Center

www.cc.nih.gov/contact.shtml

---

Contact the Department Clinical Research Informatics, (DCRI) for:

• Technical questions about Adobe Acrobat and the PDF format
• Technical questions about this web server

webmaster@cc.nih.gov